Certified by Founder Lodge 
                                        
                                        ShangBay Capital
 
                                                 United States  -  Palo Alto, California 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $22,000,000
                                            11 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            ShangBay Capital is a venture capital company that brings both U.S. and global investors access to best-in-class investments in the U.S. medical devices, biotechnology, and digital health sec
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Telesair, Inc | 
                                                            January, 12 ,2023 | Series A | $22,000,000 | 
   Flare Therapeutics | 
                                                            March, 23 ,2023 | Series B | $123,000,000 | 
   Noah Medical | 
                                                            April, 20 ,2023 | Series B | $150,000,000 | 
   Solenic Medical | 
                                                            June, 21 ,2023 | Series A | $5,100,000 | 
   Presidio Medical, Inc. | 
                                                            June, 27 ,2023 | Series C | $72,000,000 | 
   Luminopia | 
                                                            June, 29 ,2023 | Series A | $16,000,000 | 
   Laplace Interventional | 
                                                            July, 25 ,2023 | Series B | $12,900,000 | 
   Avation Medical | 
                                                            February, 02 ,2024 | Unknown | $22,000,000 | 
   Venova Medical, Inc. | 
                                                            September, 05 ,2024 | Series B | $30,000,000 | 
   Inquis Medical, Inc. | 
                                                            November, 05 ,2024 | Series B | $40,000,000 | 
   Fluid Biomed Inc. | 
                                                            December, 18 ,2024 | Series A | $27,000,000 | 
                                                
  Telesair, Inc
  Flare Therapeutics
  Noah Medical
  Solenic Medical
  Presidio Medical, Inc.
  Luminopia
  Laplace Interventional
  Avation Medical
  Venova Medical, Inc.
  Inquis Medical, Inc.
  Fluid Biomed Inc.
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)